Traws Pharma's total assets for Q2 2025 were $15.62B, an increase of 81849.33% from the previous quarter. TRAW total liabilities were $7.36B for the fiscal quarter, a 56242.34% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.